A

NNNN

ANBIO BIOTECHNOLOGY

27.81

+0.16+0.58%
After Hours: 27.51  -0.30  -1.08%17:48 04/28 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Total Assets

30.24M

18.92M

15.81M

13.96M

4.92M

Total Current Assets

30.24M

18.53M

15.75M

13.94M

4.92M

Total Non Current Assets

0

387.44K

62.14K

15.05K

0

Total Liabilities

87.84K

1.73M

993.06K

1.41M

2.38M

Total Current Liabilities

87.84K

1.73M

993.06K

1.41M

2.38M

Total Non Current Liabilities

0

0

0

0

0

Total Equity

30.16M

17.19M

14.82M

12.55M

2.54M

Total Stockholders Equity

30.16M

17.19M

14.82M

12.55M

2.54M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

30.24M

18.92M

15.81M

13.96M

4.92M

Total Common Shares Outstanding

143.89M

142.29M

143.89M

143.89M

143.89M

Total Preferred Shares Outstanding

--

--

--

--

--